[1] |
Chen WQ, Zheng RS, Baade PD, et al. Cancer Statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2):115-132.
|
[2] |
马莉,丛笑,卞美璐,等.高危型HPV分型检测作为子宫颈癌及其癌前病变初筛手段的探讨[J].中华妇产科杂志,2015,50(4):246-252.
|
[3] |
Aqorastos T, Chatzistamatiou K, Katsamaqkas T, et al. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology[J]. PLoS One,2015,10(3):751-755.
|
[4] |
Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance[J]. Gynecol Oncol,2015,136(2):178-182.
|
[5] |
Kjær SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence[J]. J Natl Cancer Inst,2010,102(19):1478-1488.
|
[6] |
Sundström K, Eloranta S, Sparén P, et al. Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix[J]. Cancer Epidemiol Biomarkers Prev,2010,19(10):2469-2478.
|
[7] |
林晴,黄卓敏. HPV分型检测在筛查宫颈癌及癌前病变中的应用[J].中国热带医学,2016,16(1):63-65.
|
[8] |
何以丰,张梅莹,冯令达,等.口腔HPV携带者子宫颈病变的发病风险分析[J].中华妇产科杂志,2013,48(8):611-617.
|
[9] |
郭周庆,徐宁,吴又明.液基细胞学结合HPV高危分型检测对宫颈病变应用价值的评估[J].实验与检验医学,2014,32(3):254-255.
|
[10] |
单玮,张涛,张铁军,等.我国女性人乳头瘤病毒(HPV)感染的流行病学现状[J].中华疾病控制杂志,2017,21(1):89-93.
|
[11] |
刘小文,虞敏,欧阳冬英,等.景德镇地区妇女人乳头瘤病毒感染与宫颈上皮病变关系的分析[J].实验与检验医学,2017,35(4):606-609.
|
[12] |
马莉,丛笑,卞美璐,等.高危型HPV分型检测作为子宫颈癌及其癌前病变初筛手段的探讨[J].中华妇产科杂志,2015,50(4):246-252.
|
[13] |
Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008 [J]. Ann Med Health Sci Res,2011,22(12):2675-2686.
|
[14] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin,2015,65(2):87-108.
|
[15] |
Banerjee J, Mishra N, Dhas Y. Metagenomics: A new horizon in cancer research [J]. Meta Gene,2015,22(5):84-89.
|
[16] |
秦宇,杨立娟,刘欧.导流杂交基因芯片技术检测人乳头瘤病毒结果分析[J].疑难病杂志,2013,12(11):865-867.
|
[17] |
侯萌,李娜,朱广霞,等.妇科门诊患者宫颈人乳头瘤病毒感染情况调查[J].西安交通大学学报(医学版),2013,34(2):229-232, 262.
|
[18] |
陶萍萍,卞美璐,欧华,等.导流杂交基因芯片技术在人乳头状瘤病毒检测中应用的研究[J].中华妇产科杂志,2006,41(1):43-47.
|
[19] |
陈志芳,马合甫扎,丁岩,等.新疆汉族,维吾尔族,哈萨克族妇女生殖道人乳头瘤病毒感染状况分析[J].中国实用妇科与产科杂志,2011,27(8):602-605.
|
[20] |
石亮程,贺骏,何玲,等.长沙市13 542例妇女HPV感染情况及基因型分布[J].吉林医学,2013,34(17):3384-3386.
|
[21] |
赵颖,林敏,潘美晨,等. HPV分型及高危八型定量检测在宫颈癌病变中的意义[J].分子诊断与治疗杂志,2013,5(2):102-106.
|
[22] |
武燕红,吕伟,郑海燕,等.乌海市3918例女性HPV基因分型结果的分析[J].分子诊断与治疗杂志,2016,8(1):32-36.
|
[23] |
苏瑞俊,杜瑞军.内蒙古自治区中西部地区妇女宫颈人乳头瘤病毒感染现状调查分析[J].分子诊断与治疗杂志,2011,3(3):173-176.
|
[24] |
李继慧,罗宇迪,张炬光,等. 3 150例妇女宫颈乳头状瘤病毒感染的调查分析[J].广西医学,2014,5(36):677-679.
|